Advertisement
Research Article Free access | 10.1172/JCI108926
Find articles by Reichl, D. in: JCI | PubMed | Google Scholar
Find articles by Myant, N. in: JCI | PubMed | Google Scholar
Find articles by Brown, M. in: JCI | PubMed | Google Scholar
Find articles by Goldstein, J. in: JCI | PubMed | Google Scholar
Published January 1, 1978 - More info
We have compared the ability of human serum and peripheral lymph to suppress the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), to activate cholesteryl ester synthesis, and to compete with 125I-labeled low density lipoprotein (LDL) for binding to LDL receptors in cultured human fibroblasts. Whole lymph was active in all three tests and the activity per unit volume in lymph was approximately equal to 1/10th that in serum. All three biologic activities in lymph were confined to the d less than 1.063 g/ml fraction. Whole lymph had no significant effect on HMG-CoA reductase activity in fibroblasts from a patient with homozygous familial hypercholesterolemia, whose cells lack LDL receptors. The LDL-like biologic activity per unit mass of immunologically active apoprotein B was approximately the same in lymph as in serum. The current data indicate that functionally active LDL is present in lymph and that the concentration of this lipoprotein is approximately equal to 1/10th that in serum.